Skip Nav Destination
Issues
Symposium on Human Insulin of Recombinant DNA Origin
Pharmacology
Clinical Pharmacologic Studies with Human Insulin (recombinant DNA)
Diabetes Care November 1982, Vol.5, 13-22. doi:https://doi.org/10.2337/diacare.5.2.S13
Absorption Kinetics of Semisynthetic Human Insulin and Biosynthetic (recombinant DNA)Human Insulin
Diabetes Care November 1982, Vol.5, 23-28. doi:https://doi.org/10.2337/diacare.5.2.S23
Plasma Insulin and C-Peptide After Subcutaneous and Intravenous Administration of Human Insulin (recombinant DNA) and Purified Porcine Insulin in Healthy Men
John C Pickup; Rudolf W Bilous; Gian Carlo Viberti; Harry Keen; R John Jarrett; Alan Glynne; Joan Cauldwell; Mary Root; Arthur H Rubenstein
Diabetes Care November 1982, Vol.5, 29-34. doi:https://doi.org/10.2337/diacare.5.2.S29
Clinical Pharmacology of Human Insulin of Recombinant DNA Origin in Healthy Volunteers
Diabetes Care November 1982, Vol.5, 35-38. doi:https://doi.org/10.2337/diacare.5.2.S35
Crossover Study with Human Insulin (recombinant DNA) in Type I Diabetic Subjects
Diabetes Care November 1982, Vol.5, 39-42. doi:https://doi.org/10.2337/diacare.5.2.S39
Search for the Most Practical Regular/NPH Mixtures for Type I Diabetic Patients
Diabetes Care November 1982, Vol.5, 53-56. doi:https://doi.org/10.2337/diacare.5.2.S53
Comparison of the Activity Profiles of Two Fixed Combinations of Regular/NPH Human Insulin (recombinant DNA) of Different Compositions with a Fixed Regular/NPH Porcine Insulin Combination (PPI) in Insulin-dependent Diabetic Individuals
Diabetes Care November 1982, Vol.5, 57-59. doi:https://doi.org/10.2337/diacare.5.2.S57
Comparative Study of NPH Human Insulin (recombinant DNA) and Pork Insulin in Diabetic Subjects: Preliminary Report
Diabetes Care November 1982, Vol.5, 60-62. doi:https://doi.org/10.2337/diacare.5.2.S60
Comparative Study of NPH Human Insulin (recombinant DNA) and NPH Bovine Insulin in Diabetic Subjects
Diabetes Care November 1982, Vol.5, 63-66. doi:https://doi.org/10.2337/diacare.5.2.S63
Pharmacodynamics of Human Insulin (recombinant DNA)—Regular, NPH, and Mixtures—Obtained by the Gerritzen Method in Healthy Volunteers
Diabetes Care November 1982, Vol.5, 67-70. doi:https://doi.org/10.2337/diacare.5.2.S67
Time-Action Profile of Zinc Human Insulin (recombinant DNA) in Young Volunteers as Compared with Zinc Porcine Insulin (Monotard)
Diabetes Care November 1982, Vol.5, 71-72. doi:https://doi.org/10.2337/diacare.5.2.S71
Biologic Effect
The Therapeutic Efficacy of Human Insulin (recombinant DNA) in Patients with Insulin-dependent Diabetes Mellitus: A Comparative Study with Purified Porcine Insulin
Daniel C Howey; S Edwin Fineberg; Phyllis A Nolen; Margaret I Stone; Reid G Gibson; Naomi S Fineberg; John A Galloway
Diabetes Care November 1982, Vol.5, 73-77. doi:https://doi.org/10.2337/diacare.5.2.S73
Different Counterregulatory Responses to Human Insulin (recombinant DNA) and Purified Pork Insulin
Diabetes Care November 1982, Vol.5, 78-81. doi:https://doi.org/10.2337/diacare.5.2.S78
Comparative Studies on Intermediary Metabolism and Hormonal Counterregulation Following Human Insulin (recombinant DNA) and Purified Pork Insulin in Man
Diabetes Care November 1982, Vol.5, 82-89. doi:https://doi.org/10.2337/diacare.5.2.S82
Less Pronounced Changes in Serum Potassium and Epinephrine During Hypoglycemia Induced by Human Insulin (recombinant DNA)
Diabetes Care November 1982, Vol.5, 90-92. doi:https://doi.org/10.2337/diacare.5.2.S90
Inhibition of Pancreatic Glucagon Responses to Arginine by Human Insulin (recombinant DNA) and Purified Porcine Insulin in Normal and Diabetic Subjects
Sotos Raptis; Dimitrios Hadjidakis; Franz Enzmann; Athanassios Raptis; Emmanuel Diamantopoulos; Julian Rosenthal
Diabetes Care November 1982, Vol.5, 93-101. doi:https://doi.org/10.2337/diacare.5.2.S93
Comparison of Biologic Potency of Human Insulin (recombinant DNA) and Purified Porcine Insulin (PPI) on the Rat and Human Adipocyte Lipogenesis Model
Diabetes Care November 1982, Vol.5, 102-103. doi:https://doi.org/10.2337/diacare.5.2.S102
Receptor Binding Properties of Human Insulin (recombinant DNA) and Human Proinsulin and Their Interaction at the Receptor Site
Diabetes Care November 1982, Vol.5, 104-106. doi:https://doi.org/10.2337/diacare.5.2.S104
Immunologic Effects
Immunologic Improvement Resulting from the Transfer of Animal Insulin–treated Diabetic Subjects to Human Insulin (recombinant DNA)
Diabetes Care November 1982, Vol.5, 107-113. doi:https://doi.org/10.2337/diacare.5.2.S107
Development of IgE Antibodies to Human (recombinant DNA), Porcine, and Bovine Insulins in Diabetic Subjects
Diabetes Care November 1982, Vol.5, 119-125. doi:https://doi.org/10.2337/diacare.5.2.S119
Insulin-Specific IgG and IgE Antibody Response in Type I Diabetic Subjects Exclusively Treated with Human Insulin (recombinant DNA)
Diabetes Care November 1982, Vol.5, 126-128. doi:https://doi.org/10.2337/diacare.5.2.S126
Clinical Trials
A Double-Blind Crossover Trial Comparing Human Insulin (recombinant DNA) with Animal Insulins in the Treatment of Previously Insulin-treated Diabetic Patients
Adrian J Clark; Philip G Wiles; James M Leiper; Graham Knight; Rodney O Adeniyi-Jones; Peter J Watkins; John D Ward; Angus C MacCuish; Harry Keen; Richard H Jones
Diabetes Care November 1982, Vol.5, 129-134. doi:https://doi.org/10.2337/diacare.5.2.S129
The U.S. “New Patient” and “Transfer” Studies
John A Galloway; F Bruce Peck, Jr; S Edwin Fineberg; C Thomas Spradlin; John H Marsden; Debra Allemenos; Joann Ingulli-Fattic
Diabetes Care November 1982, Vol.5, 135-139. doi:https://doi.org/10.2337/diacare.5.2.S135
Treatment with Human Insulin (recombinant DNA) in Diabetic Subjects Pretreated with Pork or Beef Insulin: First Results of a Multicenter Study
J Beyer; F Enzmann; M Lauerbach; P Althoff; W Bachmann; K Brandstetter; U Cordes; A Dannehl; G Düntsch; R Haas; K Heun; L Kerp; N Lotz; H Mehnert; H-J Mitzkat; K Petersen; C Rosak; D Sailer; K Schlüter; K Schöffling; K E Schröder; P Schumm; T Weber
Diabetes Care November 1982, Vol.5, 140-148. doi:https://doi.org/10.2337/diacare.5.2.S140
Case Reports and Clinical Experience
Human Insulin (recombinant DNA) in the Treatment of Patients with Newly Diagnosed Insulin-dependent Diabetes Mellitus (IDDM)
Diabetes Care November 1982, Vol.5, 149-151. doi:https://doi.org/10.2337/diacare.5.2.S149
Receptor Binding Studies and Clinical Effects of Human Insulin (recombinant DNA): Studies in Patients with Newly Diagnosed Type I Diabetes, Type II Diabetes, Insulin Resistance (Type A and Type B), Insulin Antibodies, Insulin Allergy, and “Brittle” Diabetes
Diabetes Care November 1982, Vol.5, 152-160. doi:https://doi.org/10.2337/diacare.5.2.S152
Efficiency of Human Insulin (recombinant DNA) in the Treatment of Diabetic Ketoacidosis and Severe Nonketoacidotic Hyperglycemia
Diabetes Care November 1982, Vol.5, 161-164. doi:https://doi.org/10.2337/diacare.5.2.S161
Intradermal Desensitization with Human Insulin (recombinant DNA) in a Patient with Severe Allergic Skin Reaction due to Insulin
Diabetes Care November 1982, Vol.5, 165-167. doi:https://doi.org/10.2337/diacare.5.2.S165
Insulin Allergy Treated with Human Insulin (recombinant DNA)
Diabetes Care November 1982, Vol.5, 168-170. doi:https://doi.org/10.2337/diacare.5.2.S168
Decrease of Circulating Insulin Antibodies in Two Patients Treated with Continuous Subcutaneous Infusion of Human Insulin (recombinant DNA)
Diabetes Care November 1982, Vol.5, 171-174. doi:https://doi.org/10.2337/diacare.5.2.S171
Successful Treatment of Immune-mediated Insulin Resistance by Human Insulin (recombinant DNA)
Diabetes Care November 1982, Vol.5, 175-179. doi:https://doi.org/10.2337/diacare.5.2.S175
Treatment of a Diabetic Vegetarian with Human Insulin (recombinant DNA): A Case Report
Diabetes Care November 1982, Vol.5, 180. doi:https://doi.org/10.2337/diacare.5.2.S180